Stay updated on Filgotinib and Lanraplenib in Female CLE Clinical Trial

Sign up to get notified when there's something new on the Filgotinib and Lanraplenib in Female CLE Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Filgotinib and Lanraplenib in Female CLE Clinical Trial page

  1. Check
    2 days ago
    No Change Detected
  2. Check
    9 days ago
    Change Detected
    Summary
    The page revision updated from v3.6.4 to v3.6.5, indicating a small backend/template update rather than substantive changes to visible content.
    Difference
    0.0%
    Check dated 2026-08-12T20:37:14.000Z thumbnail image
  3. Check
    16 days ago
    No Change Detected
  4. Check
    24 days ago
    Change Detected
    Summary
    The page revision label was updated from v3.6.3 to v3.6.4, reflecting a minor version update to the page metadata rather than substantive changes to the study details.
    Difference
    0.0%
    Check dated 2026-07-28T13:42:37.000Z thumbnail image
  5. Check
    53 days ago
    Change Detected
    Summary
    The page shows a new revision label, updating from Revision: v3.6.0 to Revision: v3.6.3, reflecting a newer site release. This update appears to be a software revision rather than a change to the study data or page content.
    Difference
    0.0%
    Check dated 2026-06-30T02:30:44.000Z thumbnail image
  6. Check
    67 days ago
    Change Detected
    Summary
    The page adds new help sections (How to Read a Study Record, Common Questions, How to Join a Study) and a recruitment notice indicating no participants are being sought. It also updates the Intervention/Treatment label formatting and the site revision from v3.5.5 to v3.6.0.
    Difference
    0.4%
    Check dated 2026-06-15T20:47:10.000Z thumbnail image
  7. Check
    74 days ago
    Change Detected
    Summary
    The page now shows a new software revision label (v3.5.5) in place of the previous one (v3.5.4), reflecting a software version update to the page rendering.
    Difference
    0.0%
    Check dated 2026-06-08T17:16:24.000Z thumbnail image
  8. Check
    89 days ago
    Change Detected
    Summary
    Lakefront Biotherapeutics NV was added as a collaborator and Galapagos NV was removed from the study's Collaborators and Investigators list.
    Difference
    0.0%
    Check dated 2026-05-25T10:22:38.000Z thumbnail image

Stay in the know with updates to Filgotinib and Lanraplenib in Female CLE Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Filgotinib and Lanraplenib in Female CLE Clinical Trial page.